- Home
- RVPHW vs STRRP Comparison
RVPHW vs STRRP Comparison
Compare RVPHW & STRRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- STRRP
- Stock Information
- Founded
- RVPHW 2018
- STRRP N/A
- Country
- RVPHW United States
- STRRP United States
- Employees
- RVPHW 14
- STRRP 194
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RVPHW Health Care
- STRRP Health Care
- Exchange
- RVPHW Nasdaq
- STRRP Nasdaq
- Market Cap
- RVPHW N/A
- STRRP N/A
- IPO Year
- RVPHW N/A
- STRRP N/A
- Fundamental
- Price
- RVPHW $0.04
- STRRP $9.23
- Analyst Decision
- RVPHW
- STRRP
- Analyst Count
- RVPHW 0
- STRRP 0
- Target Price
- RVPHW N/A
- STRRP N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- STRRP N/A
- Earning Date
- RVPHW 03-14-2025
- STRRP N/A
- Dividend Yield
- RVPHW N/A
- STRRP N/A
- EPS Growth
- RVPHW N/A
- STRRP N/A
- EPS
- RVPHW N/A
- STRRP N/A
- Revenue
- RVPHW N/A
- STRRP N/A
- Revenue This Year
- RVPHW N/A
- STRRP N/A
- Revenue Next Year
- RVPHW N/A
- STRRP N/A
- P/E Ratio
- RVPHW N/A
- STRRP N/A
- Revenue Growth
- RVPHW N/A
- STRRP N/A
- 52 Week Low
- RVPHW $0.13
- STRRP N/A
- 52 Week High
- RVPHW $0.15
- STRRP N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- STRRP 55.70
- Support Level
- RVPHW N/A
- STRRP $9.01
- Resistance Level
- RVPHW N/A
- STRRP $9.29
- Average True Range (ATR)
- RVPHW 0.00
- STRRP 0.03
- MACD
- RVPHW 0.00
- STRRP 0.03
- Stochastic Oscillator
- RVPHW 0.00
- STRRP 82.86
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.